SEJAL OTERO: Open Payments
NPI 1215024898 · JEFFERSON VALLEY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,716 in 237 payments from 27 companies in 2025. Trend: 2023 $5,570 · 2024 $5,777 · 2025 $5,716
Food & beverage: $5,531Education: $185
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 30 | $797 |
| ABBVIE INC. | 29 | $652 |
| Bayer Healthcare Pharmaceuticals Inc. | 20 | $498 |
| Novo Nordisk Inc | 19 | $461 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 24 | $456 |
| Lilly USA, LLC | 21 | $407 |
| Astellas Pharma US Inc | 8 | $331 |
| SHIELD THERAPEUTICS INC | 6 | $299 |
| PFIZER INC. | 15 | $219 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $192 |
Products named: Kerendia, XIFAXAN, UBRELVY, MOUNJARO, REXULTI, ACCRUFER, AIRSUPRA, FARXIGA.
Industry payments across NY — which companies pay providers there.
